Effectively Starting and Titrating Intrathecal Analgesic Therapy in Patients With Refractory Cancer Pain

Patrick J. Coyne

Tom Smith

Jill Laird

Lea Ann Hansen

David Drake

CJON 2005, 9(5), 581-583. DOI: 10.1188/05.CJON.581-583

Patients continue to suffer from pain despite their analgesic regimen and frequently from symptoms related to these interventions. This article describes the role that intrathecal analgesia may play in improving comfort for individuals experiencing refractory pain and/or symptoms of opioid therapy. Patient selection, staff education, institution requirements, medications, and titration guidelines also will be reviewed. Patients with cancer clearly deserve to achieve comfort; therefore, intrathecal therapy, which is a safe intervention, must be considered when refractory pain or symptoms occur.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.